Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
!!Search content at Experts@Minnesota
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Impacts
ANBL1531: The Children’s Oncology Group (COG) Experience Using a Bayesian Approach
Arlene Naranjo
, Rochelle Bagatell
, Emily G. Greengard
, Steven G. DuBois
Pediatric Hematology/Oncology
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'ANBL1531: The Children’s Oncology Group (COG) Experience Using a Bayesian Approach'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Childrens
100%
Oncology
100%
Bayesian Approach
100%
Anaplastic Lymphoma Kinase
100%
Group Experiences
100%
Treatment Assignment
66%
123I-MIBG
66%
Improved Outcomes
33%
Phase I Trial
33%
Newly Diagnosed
33%
Multi-arm
33%
131I-metaiodobenzylguanidine
33%
Kinase Cascade
33%
Targeted Inhibitors
33%
High-risk Neuroblastoma
33%
Medicine and Dentistry
Oncology
100%
Arm
100%
(3 Iodobenzyl)guanidine
100%
Anaplastic Lymphoma Kinase
100%
Diseases
66%
Clinical Trial
33%
Ganglioneuroblastoma
33%
Iodine 131
33%
Biochemistry, Genetics and Molecular Biology
Anaplastic Lymphoma Kinase
100%
Iobenguane
100%
Clinical Trial
33%
Wild Type
33%
Iodine-131
33%